Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$797K Sell
6,199
-9
-0.1% -$1.05K 0.34% 19
2026
Q1
$747K Hold
6,208
0.38% 18
2025
Q4
$653K Sell
6,208
-1,894
-23% -$178K 0.32% 21
2025
Q3
$680K Hold
8,102
0.34% 21
2025
Q2
$641K Buy
8,102
+478
+6% +$38K 0.34% 20
2025
Q1
$684K Hold
7,624
0.41% 18
2024
Q4
$758K Hold
7,624
0.45% 19
2024
Q3
$866K Hold
7,624
0.52% 17
2024
Q2
$944K Sell
7,624
-24
-0.3% -$3.09K 0.6% 17
2024
Q1
$1.01M Buy
+7,648
New +$943K 0.66% 16

Other funds holding MRK

Gray Private Wealth's MRK Position: Q2 2026 in Review

Gray Private Wealth reduced its Merck (MRK) stake by 0.14% in Q2 2026, selling an estimated $1.05K and leaving 6,199 shares worth $797K. The position accounts for 0.34% of the portfolio, ranked #19.

Gray Private Wealth first reported a position in MRK in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.01M in Q1 2024. 3,815 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Gray Private Wealth held 6,199 shares of Merck worth $797K as of Q2 2026.
  • Gray Private Wealth sold 9 Merck shares in Q2 2026, an estimated $1.05K.
  • Merck made up 0.34% of Gray Private Wealth's portfolio in Q2 2026, its #19 holding.
  • Gray Private Wealth first reported a position in Merck in Q1 2024 and has held it in 10 quarters since.
  • Gray Private Wealth's Merck position peaked at $1.01M in Q1 2024.
  • 3,815 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Gray Private Wealth's 13F filing for Q2 2026, filed 24 Jul 2026.